GL0034 is a novel, investigational glucagon-like peptide 1 receptor agonist (GLP-1RA) being studied for the treatment of type 2 diabetes and obesity
This partnership will revolutionize Pharmarack's digital infrastructure with Snowflake's single, integrated platform to facilitate advanced analytic
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
Approximately 60 to 78% of individuals diagnosed with Asthma also have concurrent Allergic Rhinitis
Total investments could reach €70 million, of which approximately 15% in R&D and 85% in capex, that would be deployed from 2026
_256_384.jpeg)
Launched Pathology Laboratory in Vijayawada offering a wide range of best-in-class diagnostic services with over 2500+ tests
Pfizer is likely to show GSK significant competition
The new lab will enable the Group to accelerate its efforts in this area, building new competencies and capabilities, as well as strengthening Solvay’s ability to develop breakthroughs in biodegradable-by-design solutions.
The EU certification will support supplies of drug products registered in Europe, from this manufacturing site
Subscribe To Our Newsletter & Stay Updated
